Dear Ministry of Health,

In response to your query dated 18th May 2018, my main questions "Could you please tell me who and where the research was done? Was it research that the company selling the drug did or was it confirmed by independent researchers?" are in relationship to the research quoted in the information provided by Medsafe -

http://www.medsafe.govt.nz/profs/Datashe...

which is their information sheet about Enlafax, on their website.
Yours faithfully,

Yours faithfully,
Trudi Webber

Dear Ministry of Health,

Dear Mr James,

Thank you for your reply to my request for information under the OIA. In response to your reply I have have a few questions that I would like answered as part of the request under the OIA.

Could you please send me copies of the documents Mylan supplied showing that Enlafax XR is bioequivalent to Effexor XR.

You also refer to the the fact that Enlafax has been approved for supply in the USA, Canada, UK, France and Australia but I can find no reference to Enlafax being available in any of those countries except Australia. Is Enlafax sold under a different brand name by Mylan in these countries, and if so could you please inform me what they are.

I would also like to query what knowledge you have surrounding the reports of adverse effects caused to patients by Enlafax in Australia.

Yours faithfully,

Trudi Webber

Dear Ministry of Health,

I have received your reply to my request but unfortunately I cannot download the file. Could you please send the response to the following email address - [email address] and I will try to download it from there.
Thank you

Yours faithfully,

Trudi Webber